Sabra Healthcare REIT (SBRA)
(Delayed Data from NSDQ)
$13.94 USD
+0.29 (2.12%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $13.94 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum D VGM
Income Statements
Fiscal Year end for Sabra Healthcare REIT, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 648 | 625 | 570 | 599 | 662 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 648 | 625 | 570 | 599 | 662 |
Selling & Adminstrative & Depr. & Amort Expenses | 440 | 484 | 368 | 347 | 444 |
Income After Depreciation & Amortization | 207 | 141 | 201 | 252 | 218 |
Non-Operating Income | -76 | -14 | -22 | 4 | -12 |
Interest Expense | 113 | 105 | 99 | 100 | 127 |
Pretax Income | 19 | 22 | 81 | 156 | 79 |
Income Taxes | 2 | 1 | 2 | 1 | 3 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | -3 | -98 | -192 | -17 | -7 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 14 | -78 | -113 | 138 | 69 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 14 | -78 | -113 | 138 | 69 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 390 | 328 | 380 | 428 | 399 |
Depreciation & Amortization (Cash Flow) | 183 | 188 | 179 | 177 | 182 |
Income After Depreciation & Amortization | 207 | 141 | 201 | 252 | 218 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 232.79 | 230.95 | 219.07 | 207.25 | 188.13 |
Diluted EPS Before Non-Recurring Items | 0.06 | -0.34 | -0.52 | 0.67 | 0.37 |
Diluted Net EPS (GAAP) | 0.06 | -0.34 | -0.52 | 0.67 | 0.37 |
Fiscal Year end for Sabra Healthcare REIT, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 163.40 | 161.63 | 161.17 | 161.32 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 163.40 | 161.63 | 161.17 | 161.32 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 116.35 | 103.15 | 102.84 | 117.99 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 47.05 | 58.48 | 58.33 | 43.33 |
Non-Operating Income | NA | -0.70 | -44.32 | -7.83 | -22.72 |
Interest Expense | NA | 27.94 | 28.16 | 28.33 | 28.54 |
Pretax Income | NA | 18.41 | -14.00 | 22.17 | -7.92 |
Income Taxes | NA | 0.49 | 0.46 | 0.33 | 0.73 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | -0.76 | -0.65 | -0.65 | -0.84 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 17.16 | -15.10 | 21.19 | -9.49 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 17.16 | -15.10 | 21.19 | -9.49 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 233.20 | 231.23 | 232.25 | 231.17 |
Diluted EPS Before Non-Recurring Items | NA | 0.07 | -0.07 | 0.09 | -0.04 |
Diluted Net EPS (GAAP) | NA | 0.08 | -0.07 | 0.09 | -0.04 |